Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models
Kiyomi Mashima(Jichi Medical University), Yoshinobu Kanda(Jichi Medical University)
Cited by 9
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
|Blood|2017|352
Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome
|Leukemia|2005|119
Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2017|116
Mutations Detected in Real World Clinical Sequencing during BTK Inhibitor Treatment in CLL
|Research Square|2024|13